Last reviewed · How we verify
Vitamin D tablets
Vitamin D tablets provide cholecalciferol (vitamin D3) to regulate calcium and phosphate homeostasis and support immune and bone health.
Vitamin D tablets provide cholecalciferol (vitamin D3) to regulate calcium and phosphate homeostasis and support immune and bone health. Used for Vitamin D deficiency, Osteoporosis prevention and treatment, Rickets.
At a glance
| Generic name | Vitamin D tablets |
|---|---|
| Sponsor | Ain Shams University |
| Drug class | Vitamin supplement |
| Target | Vitamin D receptor (VDR) |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplementation / Bone health |
| Phase | FDA-approved |
Mechanism of action
Vitamin D is a fat-soluble vitamin that acts as a hormone precursor. After absorption, it is converted in the liver to 25-hydroxyvitamin D and then in the kidneys to the active form, 1,25-dihydroxyvitamin D, which binds to vitamin D receptors to enhance intestinal calcium absorption, regulate bone mineralization, and modulate immune function.
Approved indications
- Vitamin D deficiency
- Osteoporosis prevention and treatment
- Rickets
- Hypocalcemia
Common side effects
- Hypercalcemia (at high doses)
- Nausea
- Constipation
- Headache
Key clinical trials
- Effects of Cofrogliptin on Beta-Cell Function in LADA Patients (NA)
- Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment (NA)
- Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood (PHASE1)
- Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients (PHASE3)
- PREDIN: Pregnancy and Vitamin D Intervention Study (NA)
- Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients (PHASE2)
- Genetic Alterations From Physical Therapy in Low Back Pain and Disc Degeneration (NA)
- PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vitamin D tablets CI brief — competitive landscape report
- Vitamin D tablets updates RSS · CI watch RSS
- Ain Shams University portfolio CI